# LOTEMAX SM
> **NDA208219** · New Drug Application · Sponsor: BAUSCH AND LOMB INC · Approved 2019-02-22
## Drug
- **FDA Application Number:** NDA208219
- **Application type:** New Drug Application
- **Brand name:** LOTEMAX SM
- **Generic name:** LOTEPREDNOL ETABONATE
- **Active ingredients:** LOTEPREDNOL ETABONATE
- **Dosage form:** GEL
- **Route:** OPHTHALMIC
- **Marketing status:** Prescription
- **Sponsor:** BAUSCH AND LOMB INC
- **Manufacturer:** Bausch & Lomb Incorporated
- **First approval:** 2019-02-22
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208219)
---
*AI Analytics · CC0 1.0*